619Methylated glutathione-S-transferase P1 in prostate biopsy needle washing solution as an additional diagnostic tool

2005 ◽  
Vol 4 (3) ◽  
pp. 157
Author(s):  
M. Auprich ◽  
H. Augustin ◽  
S. Mannweiler ◽  
P. Rehak ◽  
G. Tilz ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Diagnostic Tool ◽  
Glutathione S Transferase ◽  
Biopsy Needle

Opisthorchis viverrini: Evaluation of 28kDa glutathione S-transferase as diagnostic tool in human opisthorchiasis

Acta Tropica ◽  
2010 ◽  
Vol 114 (2) ◽  
pp. 76-80 ◽  
Author(s):  
Veerachai Eursitthichai ◽  
Vithoon Viyanant ◽  
Smarn Tesana ◽  
Paiboon Sithithaworn ◽  
Nanthawat Kosa ◽  
...  
Keyword(s):  
Diagnostic Tool ◽  
Opisthorchis Viverrini ◽  
Glutathione S Transferase

scholarly journals The use of European Randomized study of Screening for Prostate Cancer calculator as a diagnostic tool for prostate biopsy indication

2019 ◽  
Vol 120 (05) ◽  
pp. 331-335
Author(s):  
J. Breza ◽  
F. Subin ◽  
M. Bernadic ◽  
M. Tomas ◽  
D. Pindak
Keyword(s):  
Prostate Cancer ◽  
Prostate Biopsy ◽  
Diagnostic Tool ◽  
Randomized Study

First Place: Sustained-Release Antibacterial Varnish-Coated Biopsy Needle for Reduction of Infection Rates Following Prostate Biopsy—In Vitro Model

2013 ◽  
Vol 27 (3) ◽  
pp. 277-283 ◽  
Author(s):  
Gideon Lorber ◽  
Mordechai Duvdevani ◽  
Michael Friedman ◽  
Eran Lavy ◽  
Ezekiel H. Landau ◽  
...  
Keyword(s):  
Sustained Release ◽  
Prostate Biopsy ◽  
In Vitro Model ◽  
Infection Rates ◽  
Biopsy Needle ◽  
Vitro Model

scholarly journals Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link

2013 ◽  
Vol 7 (9-10) ◽  
pp. 567 ◽  
Author(s):  
Antonio Cicione ◽  
Francesco Cantiello ◽  
Cosimo De Nunzio ◽  
Andrea Tubaro ◽  
Rocco Damiano
Keyword(s):  
Prostate Cancer ◽  
Gleason Score ◽  
Prostate Biopsy ◽  
Specific Antigen ◽  
Kappa Statistic ◽  
Study Groups ◽  
Localized Prostate Cancer ◽  
Needle Size ◽  
Biopsy Needle ◽  
Biopsy Gleason Score

Background: Biopsy Gleason score (GS), in combination with other clinical parameters, is important to take a therapeutic decision for patients with diagnosis of localized prostate cancer. However, preoperative GS is often upgraded after a radical prostatectomy. Increasing the amount of tissue in prostate biopsy may be a way to avoid this issue. We evaluate the influence of a larger biopsy needle size on the concordance between biopsy and pathological GS.Methods: We analyzed paired biopsies and prostatectomy specimens from 104 cases of men with clinically localized prostate cancer. At the time of prostate biopsy, the patients were prospectively randomized into two needle groups (16-Gauge [G] and 18G) using a 1:1 ratio. GS concordance was estimated performing kappa statistic testing, overall concordance rate and risk to under grade biopsy GS=6. A logistic regression analysis was performed to evaluate the patients’ characteristics as possible risk factors.Results: The overall concordance between prostate biopsy and pathological GS was 76.9% and 75.6% (p = 0.875) and the k values were 0.821 and 0.811 (p = 0.424), respectively, for 16G and 18G needle study groups. The risk to undergrade a biopsy GS=6 was 21.1% and 15.4% (p = 0.709) using a 16G and 18G needle, respectively. Age, prostate-specific antigen, prostate volume and needle calibre were not independently associated with a higher risk of GS discordance.Conclusions: Needle size does not affect the concordance between biopsy and pathological GS. Although GS is not the only way to determine treatment, it is still an unresolved urological issue.

19 SIXES CORES PROSTATE BIOPSY. FOR WHOM IT IS STILL JUSTIFIED AS INITIAL DIAGNOSTIC TOOL FOR DETECTION OF THE PROSTATE CANCER?

2010 ◽  
Vol 9 (2) ◽  
pp. 40
Author(s):  
P. Milonas ◽  
A. Zabarskas ◽  
J. Masiliunas ◽  
M. Jievaltas
Keyword(s):  
Prostate Cancer ◽  
Prostate Biopsy ◽  
Diagnostic Tool

Disinfection of a Probe Used in Ultrasound-Guided Prostate Biopsy

2007 ◽  
Vol 28 (8) ◽  
pp. 916-919 ◽  
Author(s):  
William A. Rutala ◽  
Maria F. Gergen ◽  
David J. Weber
Keyword(s):  
Prostate Biopsy ◽  
Bacterial Load ◽  
Transrectal Ultrasound ◽  
Diagnostic Procedures ◽  
Ultrasound Probe ◽  
Ultrasound Guided ◽  
Biopsy Needle ◽  
Prostate Biopsies ◽  
Colony Forming Units ◽  
High Level

Background.Transrectal ultrasound (TRUS)-guided prostate biopsies are among the most common outpatient diagnostic procedures in urology clinics and carry the risk of introducing pathogens that may lead to infection.Objective.To investigate the effectiveness of procedures for disinfecting a probe used in ultrasound-guided prostate biopsy.Method.The effectiveness of disinfection was determined by inoculating 107 colony forming units (cfu) of Pseudomonas aeruginosa at the following 3 sites on the probe: the interior lumen of the biopsy needle guide, the outside surface of the biopsy needle guide, and the interior lumen of the ultrasound probe where the needle guide passes through the transducer. Each site was investigated separately. After inoculation, the probe was immersed in 2% glutaraldehyde for 20 minutes and then assessed for the level of microbial contamination.Results.The results demonstrated that disinfection (ie, a reduction in bacterial load of greater than 7 log10 cfu) could be achieved if the needle guide was removed from the probe. However, if the needle guide was left in the probe channel during immersion in 2% glutaraldehyde, disinfection was not achieved (ie, the reduction was approximately 1 log10 cfu).Conclusions.Recommendations for probe disinfection are provided and include disassembling the device and immersing the probe and the needle guide separately in a high-level disinfectant.

Sign in / Sign up

Export Citation Format

Share Document